Janssen, Johnson & Johnson partly prevail in counterfeit HIV drug row
MLex Summary: Defendants who participated in a criminal conspiracy to sell black-market HIV medicines made by Janssen Sciences and Johnson & Johnson were denied a summary judgment of no liability under...To view the full article, register now.
Already a subscriber? Click here to view full article